February x 2016 Not for Public Release CFSAN Acquisition Liaison Branch Value Proposition Key Objectives Overall Value Proposition to Support ALB Improvement Summary of Stakeholder Groups ID: 908448
Download Presentation The PPT/PDF document "Task 10: Acquisitions Improvement Suppo..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Task 10: Acquisitions Improvement Support
February
x
, 2016
Not for Public Release
CFSAN
Acquisition Liaison
Branch
Value Proposition
Slide2Key Objectives
Overall Value Proposition to Support ALB ImprovementSummary of Stakeholder GroupsDerived value by each Stakeholder Group
How Change will be achieved
2
Slide3Why is change required?ALB cannot totally fulfill its intended purpose
Liaison between requirements community and OAGSPre-SolicitationSolicitation & Quality SurveillanceSource Selection
Post AwardWhat will change?Increased resourcesRequisite training for personnelAppropriate skill set of personnel
Single POC for Stakeholder issues| 3 | Overall Value Proposition
Slide4Benefits of ChangeALB will fulfill its intended purpose
Acquisition documentation forwarded to OAGS will not require reworkRequirements community will not have to go directly to OAGSLiaison between requirements community and OAGS
Ultimately ALB will be the “One Stop Shop” model for FDAThe “Go To” shop for any acquisition support and/or consultation outside of OAGS cognizance
| 4 | Overall Value Proposition
Slide5Program OfficesOAGS
CORsFDA
| 5
|Summary of Stakeholder Groups
Slide6Program OfficesTimely requirements executionTimely obligation of funds
Acquisition document rework mitigationImproved skills of personnelOAGSReduced work effort from need to rework submitted acquisition packages
Improved relationship with Program OfficesCORsClear direction of responsibilitiesRequisite and current trainingFDA
Model ALB for others to duplicateOne Stop Shop| 6 |Derived Value by each Stakeholder Group
Slide7Increase in ALB resources is imperativeDetermine expertise required for ALBCertification
GS-SeriesExperienceCreate an environment envy of workforceImproves recruiting and retentionIncrease quantity and quality of CORs
TrainingFAC-CDAUStaff College
| 7 |How Will Change Be Achieved
Slide8Backup Slides
8
Slide9|
9 |
ALB Goals/Objectives
Operate effectively and efficiently and more affordably for CFSAN requirements.Bundle products and services for best value procurement.Remain dependable, reliable, responsiveReinforce relevance to CFSAN customers, stakeholders, mission and operations.Orchestrate complex and inter-dependent requirements.Build innovative solutions and streamlined acquisition procedures.Create a hub for FDA staff to bring together in one place. Coordinate collaborative learning for ALB staff.Enhance CFSAN presence through partnerships and collaboration.
Slide10FY15 Recap:Acquisition
10
Recommendations:
Refresh Skills of ALB StaffCommence Acquisition Cycle SoonerRe-Organize and Increase ALB StaffInstitute Functions to Control Package CycleUtilize Templates/Examples & ChecklistsEstablish Agreements with Partners
Slide11|
11 |
Slide12|
12 |
Comparative Descriptive FDA Acquisition Data
NOTE: This is NOT an Apples to Apples comparison – each acquisition function can operate very differently which would explain different staff profiles of ALB type functions